Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Reexamination Certificate
2007-11-20
2007-11-20
Kishore, Gollaamudi S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
Reexamination Certificate
active
09701220
ABSTRACT:
Use of anti-inflammatory agents such as povidone iodine for the preparation of a pharmaceutical composition for the treatment of diseases of the upper respiratory tract and/or the ear which are susceptible to the administration of such agents.
REFERENCES:
patent: 2706701 (1955-04-01), Beller et al.
patent: 4113857 (1978-09-01), Shetty
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4560678 (1985-12-01), Ranson
patent: 4675009 (1987-06-01), Hymes et al.
patent: 4906476 (1990-03-01), Radhakrishnan
patent: 4938965 (1990-07-01), Shek et al.
patent: 5034228 (1991-07-01), Meybeck et al.
patent: 5049388 (1991-09-01), Knight
patent: 5049389 (1991-09-01), Radhakrishnan
patent: 5114928 (1992-05-01), Gajdos et al.
patent: 5128139 (1992-07-01), Brown et al.
patent: 5232692 (1993-08-01), Isenberg et al.
patent: 5246708 (1993-09-01), von Borstel et al.
patent: 5290540 (1994-03-01), Prince
patent: 5456923 (1995-10-01), Nakamichi et al.
patent: 5552158 (1996-09-01), Evans et al.
patent: 5942245 (1999-08-01), Katinger et al.
patent: 2204 493 (1996-05-01), None
patent: 0260241 (1988-03-01), None
patent: 0317405 (1989-05-01), None
patent: 0404028 (1991-01-01), None
patent: 0509338 (1992-10-01), None
patent: 0613685 (1994-09-01), None
patent: 0639373 (1995-02-01), None
patent: 1013269 (2000-06-01), None
patent: 1013269 (2000-06-01), None
patent: 0-24640 (1989-02-01), None
patent: 2204413 (1990-08-01), None
patent: 7-145081 (1995-06-01), None
patent: 63126820 (1998-05-01), None
patent: 85/00112 (1985-01-01), None
patent: 8809165 (1988-12-01), None
patent: 9324165 (1988-12-01), None
patent: 9011781 (1990-10-01), None
patent: 9324165 (1993-12-01), None
patent: 9414490 (1994-07-01), None
patent: 9428876 (1994-12-01), None
patent: 9614083 (1996-05-01), None
patent: 9960999 (1999-12-01), None
patent: 9961003 (1999-12-01), None
patent: 0072823 (2000-12-01), None
Chemical Abstracts, vol. 117, No. 10 (Sep. 7, 1992); Abstract No. 97244, Brian E. Gilbert et al.,Aerosolized Liposomal Amphotericin B for Treatment of Pulmonary and Systemic Cryptococcus Neoformans Infections in Mice,36(7) Antimicrob. Agents Chemotherapy 1466-71 (1992).
Jenny Liautard, et al. “Encapulation of Drugs Into Large Unilamellar Liposomes Prepared by an Extempsaneous Method,” J. Microencapsulation, 1991, vol. 8, No. 3, 381-89.
Abstract JP 22 04413 and JP 63-126 820 (English).
P. Wüzler, et al., “Virucidal and Chalmudicidal Activites of Povidone-Iodine(PVP-l)Lipsomes,” Clin Microbial Inf 5(suppl 3) 136 (1990) 9thEuropean Conference of Clin Microbiology and Infectious Diseases, Berlin, Mar. 1999.
Bernhard Müllinger, et al., “Coated Drug Droplets Allow Individual Dosimetry,” Respiratory Drug Delivery VI, Hilton Head, S.C. May 3-7, 1998, pp. 385-387.
James F. Fitzgerald, et al., “Novel Coating For Improved Pulmonary Drug Delivery,” U. Of Florida Office of Graduate Research, Technology and Education, VF#1887, Jan. 15, 1998 (ABSTRACT).
David A. Edwards, et al., “Large Porous Particles for Pulmonary Drug Delivery,” Science, vol. 276, Jun. 20, 1997, p. 1868-1871.
H. Schreier, et al., “Formulation and in-vitro performance of liposome powder aerosels,” S.T.P. Pharma Sciences 4(1) 38-44, 1994.
Hans Schreier, et al., “Pulmonary delivery of liposomes,” Journal of Controlled Release, 24 (1993) 209-223.
Abstract EP 0613685 (English).
Abstract EP 0509338 (English).
Janine F. Bridges, et al., “The Uptake of Liposome-Entrapped I-Labelled Poly(Vinyl Pyrrolidone)By Rat Jejunum In-Vitro,”Biochemica et Biophycica Acta, 544 (1978) 448-451.
Peter M. Vogt, et al. “Polyvinyl pyrrolidone-iodine Lipsome Hydrogel Improves Epithelialization By Combing Moisture And Antisepsis. A New Concept In Wound Therapy,”Wound Repair and Regenerationvol. 9 No. 2 p. 116-122.
Karen Reimer, et al., “An Innovative Topical Drug Formulation for Wound Healing And Infection Treatment: In-Vitro and In-Vivo Investigations of a Povidone-Iodine Liposome Hydrogel,” Dermatology 2000, 201: 235-241.
Xiaonan Cia, 1994, “The Clinical Use and Dosage Form of Iodophors”, Bulletin of the Medical School of Shantou University (2):77.
Ganzer et al., 2001, Arthroskopie 14:31.
Lineaweaver et al., 1985, Arch Surg 120:257-270.
Kallengerger et al., 1991, Hyg+Med 16:383-395.
Weiner et al., 1989, Drug Development and Industrial Pharmacy, 15 (10), 1523-1554.
Vogt et al., 2001, Wound Rep. Reg. 9:116-122.
Reimer et al., 2000, Dermatology 201:235-241.
Integrated Final Study Report for HOM3401.
Fleischer Wolfgang
Reimer Karen
Euro-Celtique S.A.
Jones Day
Kishore Gollaamudi S.
LandOfFree
Preparations for the promotion of wound healing in the upper... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Preparations for the promotion of wound healing in the upper..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Preparations for the promotion of wound healing in the upper... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3886814